GSK3B and glioblastoma: In this sense, it has been recently reported in glioblastoma that GSK3β expression leads to NDRG1 degradation as a tumor suppressor and, conversely, NDRG1 overexpression induced GSK3β degradation as a bidirectional regulatory mechanism 32.